Treating Depression (and Other Disorders) with Psychedelic Drugs

Researchers in The Depression Evaluation Service (DES) at New York State Psychiatric Institute and Columbia’s Department of Psychiatry are working on innovative studies using psilocybin and other psychedelic compounds in the treatment of psychiatric symptoms and disorders. These long-neglected compounds may provide breakthroughs in treating a wide range of psychiatric disorders. We have several studies in development for which we are seeking additional funding.

To help support our work, please go to the Columbia Psychiatry Donations page. On that page, please choose the “Depression Evaluation Service Office” fund.